| [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study MS Hofman, J Violet, RJ Hicks, J Ferdinandus, SP Thang, T Akhurst, ... The Lancet Oncology 19 (6), 825-833, 2018 | 1055 | 2018 |
| Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the visual response score and the change in total lesion … SM Larson, Y Erdi, T Akhurst, M Mazumdar, HA Macapinlac, RD Finn, ... Clinical Positron Imaging 2 (3), 159-171, 1999 | 701 | 1999 |
| Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline SL Wong, CM Balch, P Hurley, SS Agarwala, TJ Akhurst, A Cochran, ... Journal of Clinical Oncology 30 (23), 2912-2918, 2012 | 514 | 2012 |
| Lessons learned from 500 cases of lymphatic mapping for breast cancer ADK Hill, KN Tran, T Akhurst, H Yeung, SDJ Yeh, PP Rosen, PI Borgen, ... Annals of surgery 229 (4), 528-535, 1999 | 477 | 1999 |
| Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection RJ Downey, T Akhurst, M Gonen, A Vincent, MS Bains, S Larson, V Rusch Journal of Clinical Oncology 22 (16), 3255-3260, 2004 | 464 | 2004 |
| Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology clinical practice … SL Wong, MB Faries, EB Kennedy, SS Agarwala, TJ Akhurst, C Ariyan, ... Journal of Clinical Oncology 36 (4), 399-413, 2018 | 454 | 2018 |
| Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors PM Smith-Jones, DB Solit, T Akhurst, F Afroze, N Rosen, SM Larson Nature biotechnology 22 (6), 701-706, 2004 | 440 | 2004 |
| Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial RJ Downey, T Akhurst, D Ilson, R Ginsberg, MS Bains, M Gonen, H Koong, ... Journal of clinical oncology 21 (3), 428-432, 2003 | 425 | 2003 |
| Dosimetry of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes J Violet, P Jackson, J Ferdinandus, S Sandhu, T Akhurst, A Iravani, ... Journal of Nuclear Medicine 60 (4), 517-523, 2019 | 414 | 2019 |
| Tumor localization of 16β-18F-fluoro-5α-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer SM Larson, M Morris, I Gunther, B Beattie, JL Humm, TA Akhurst, RD Finn, ... Journal of Nuclear Medicine 45 (3), 366-373, 2004 | 414 | 2004 |
| [18F]-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Localizes Residual Thyroid Cancer in Patients with Negative Diagnostic 131I Whole Body … W Wang, H Macapinlac, SM Larson, SDJ Yeh, T Akhurst, RD Finn, ... The Journal of Clinical Endocrinology & Metabolism 84 (7), 2291-2302, 1999 | 407 | 1999 |
| Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology T Beyer, G Antoch, T Blodgett, LF Freudenberg, T Akhurst, S Mueller European journal of nuclear medicine and molecular imaging 30, 588-596, 2003 | 394 | 2003 |
| Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas S George, P Merriam, RG Maki, AD Van den Abbeele, JT Yap, T Akhurst, ... Journal of Clinical Oncology 27 (19), 3154-3160, 2009 | 381 | 2009 |
| Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression JG Tjuvajev, M Doubrovin, T Akhurst, S Cai, J Balatoni, MM Alauddin, ... Journal of Nuclear Medicine 43 (8), 1072-1083, 2002 | 368 | 2002 |
| Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures HS Cody, J Fey, T Akhurst, M Fazzari, M Mazumdar, H Yeung, SDJ Yeh, ... Annals of surgical oncology 8, 13-19, 2001 | 360 | 2001 |
| Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of … GJ Riely, MG Kris, B Zhao, T Akhurst, DT Milton, E Moore, L Tyson, W Pao, ... Clinical cancer research 13 (17), 5150-5155, 2007 | 345 | 2007 |
| Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases Y Fong, PF Saldinger, T Akhurst, H Macapinlac, H Yeung, RD Finn, ... The American journal of surgery 178 (4), 282-287, 1999 | 341 | 1999 |
| 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer CU Corvera, LH Blumgart, T Akhurst, RP DeMatteo, M D’Angelica, Y Fong, ... Journal of the American College of Surgeons 206 (1), 57-65, 2008 | 326 | 2008 |
| Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients DC Linehan, ADK Hill, T Akhurst, H Yeung, SDJ Yeh, KN Tran, PI Borgen, ... Annals of Surgical Oncology 6, 450-454, 1999 | 297 | 1999 |
| Long-term follow-up and outcomes of retreatment in an expanded 50-patient single-center phase II prospective trial of 177Lu-PSMA-617 theranostics in metastatic castration … J Violet, S Sandhu, A Iravani, J Ferdinandus, SP Thang, G Kong, ... Journal of Nuclear Medicine 61 (6), 857-865, 2020 | 278 | 2020 |
